Long-term outcomes of switching to aflibercept for treatment-resistant neovascular age-related macular degeneration.
Kimberly L SpoonerThomas HongRashmi NairNicholas Chian Chiang ChowGeoffrey K BroadheadWijeyanthy WijeyakumarAndrew A ChangPublished in: Acta ophthalmologica (2019)
Aflibercept is an effective alternative therapy for treatment-resistant nAMD. Good anatomical and stable functional responses are achievable with continued therapy. The lack of continued visual improvement may be representative of GA progression, reflecting the progression of late-stage nAMD in these patients.